Copyright Reports & Markets. All rights reserved.

Global Fosaprepitant Dimeglumine API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Fosaprepitant Dimeglumine API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Fosaprepitant Dimeglumine API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Fosaprepitant Dimeglumine Injections
    • 1.4.3 Others
  • 1.5 Global Fosaprepitant Dimeglumine API Market Size & Forecast
    • 1.5.1 Global Fosaprepitant Dimeglumine API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Fosaprepitant Dimeglumine API Sales Quantity (2020-2031)
    • 1.5.3 Global Fosaprepitant Dimeglumine API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Dr. Reddy’s Laboratories Ltd.
    • 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
    • 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
    • 2.1.3 Dr. Reddy’s Laboratories Ltd. Fosaprepitant Dimeglumine API Product and Services
    • 2.1.4 Dr. Reddy’s Laboratories Ltd. Fosaprepitant Dimeglumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
  • 2.2 Tecoland Corporation
    • 2.2.1 Tecoland Corporation Details
    • 2.2.2 Tecoland Corporation Major Business
    • 2.2.3 Tecoland Corporation Fosaprepitant Dimeglumine API Product and Services
    • 2.2.4 Tecoland Corporation Fosaprepitant Dimeglumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Tecoland Corporation Recent Developments/Updates
  • 2.3 Wisdom Pharmaceutical Co., Ltd.
    • 2.3.1 Wisdom Pharmaceutical Co., Ltd. Details
    • 2.3.2 Wisdom Pharmaceutical Co., Ltd. Major Business
    • 2.3.3 Wisdom Pharmaceutical Co., Ltd. Fosaprepitant Dimeglumine API Product and Services
    • 2.3.4 Wisdom Pharmaceutical Co., Ltd. Fosaprepitant Dimeglumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Wisdom Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.4 Glenmark Pharmaceuticals
    • 2.4.1 Glenmark Pharmaceuticals Details
    • 2.4.2 Glenmark Pharmaceuticals Major Business
    • 2.4.3 Glenmark Pharmaceuticals Fosaprepitant Dimeglumine API Product and Services
    • 2.4.4 Glenmark Pharmaceuticals Fosaprepitant Dimeglumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.5 Viwit Pharmaceuticals Limited
    • 2.5.1 Viwit Pharmaceuticals Limited Details
    • 2.5.2 Viwit Pharmaceuticals Limited Major Business
    • 2.5.3 Viwit Pharmaceuticals Limited Fosaprepitant Dimeglumine API Product and Services
    • 2.5.4 Viwit Pharmaceuticals Limited Fosaprepitant Dimeglumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Viwit Pharmaceuticals Limited Recent Developments/Updates
  • 2.6 Piramal Enterprises limited
    • 2.6.1 Piramal Enterprises limited Details
    • 2.6.2 Piramal Enterprises limited Major Business
    • 2.6.3 Piramal Enterprises limited Fosaprepitant Dimeglumine API Product and Services
    • 2.6.4 Piramal Enterprises limited Fosaprepitant Dimeglumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Piramal Enterprises limited Recent Developments/Updates
  • 2.7 Farmhispania, S.A.
    • 2.7.1 Farmhispania, S.A. Details
    • 2.7.2 Farmhispania, S.A. Major Business
    • 2.7.3 Farmhispania, S.A. Fosaprepitant Dimeglumine API Product and Services
    • 2.7.4 Farmhispania, S.A. Fosaprepitant Dimeglumine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Farmhispania, S.A. Recent Developments/Updates

3 Competitive Environment: Fosaprepitant Dimeglumine API by Manufacturer

  • 3.1 Global Fosaprepitant Dimeglumine API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Fosaprepitant Dimeglumine API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Fosaprepitant Dimeglumine API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Fosaprepitant Dimeglumine API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Fosaprepitant Dimeglumine API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Fosaprepitant Dimeglumine API Manufacturer Market Share in 2024
  • 3.5 Fosaprepitant Dimeglumine API Market: Overall Company Footprint Analysis
    • 3.5.1 Fosaprepitant Dimeglumine API Market: Region Footprint
    • 3.5.2 Fosaprepitant Dimeglumine API Market: Company Product Type Footprint
    • 3.5.3 Fosaprepitant Dimeglumine API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Fosaprepitant Dimeglumine API Market Size by Region
    • 4.1.1 Global Fosaprepitant Dimeglumine API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Fosaprepitant Dimeglumine API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Fosaprepitant Dimeglumine API Average Price by Region (2020-2031)
  • 4.2 North America Fosaprepitant Dimeglumine API Consumption Value (2020-2031)
  • 4.3 Europe Fosaprepitant Dimeglumine API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Fosaprepitant Dimeglumine API Consumption Value (2020-2031)
  • 4.5 South America Fosaprepitant Dimeglumine API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Fosaprepitant Dimeglumine API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Fosaprepitant Dimeglumine API Sales Quantity by Type (2020-2031)
  • 5.2 Global Fosaprepitant Dimeglumine API Consumption Value by Type (2020-2031)
  • 5.3 Global Fosaprepitant Dimeglumine API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Fosaprepitant Dimeglumine API Sales Quantity by Application (2020-2031)
  • 6.2 Global Fosaprepitant Dimeglumine API Consumption Value by Application (2020-2031)
  • 6.3 Global Fosaprepitant Dimeglumine API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Fosaprepitant Dimeglumine API Sales Quantity by Type (2020-2031)
  • 7.2 North America Fosaprepitant Dimeglumine API Sales Quantity by Application (2020-2031)
  • 7.3 North America Fosaprepitant Dimeglumine API Market Size by Country
    • 7.3.1 North America Fosaprepitant Dimeglumine API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Fosaprepitant Dimeglumine API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Fosaprepitant Dimeglumine API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Fosaprepitant Dimeglumine API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Fosaprepitant Dimeglumine API Market Size by Country
    • 8.3.1 Europe Fosaprepitant Dimeglumine API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Fosaprepitant Dimeglumine API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Fosaprepitant Dimeglumine API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Fosaprepitant Dimeglumine API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Fosaprepitant Dimeglumine API Market Size by Region
    • 9.3.1 Asia-Pacific Fosaprepitant Dimeglumine API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Fosaprepitant Dimeglumine API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Fosaprepitant Dimeglumine API Sales Quantity by Type (2020-2031)
  • 10.2 South America Fosaprepitant Dimeglumine API Sales Quantity by Application (2020-2031)
  • 10.3 South America Fosaprepitant Dimeglumine API Market Size by Country
    • 10.3.1 South America Fosaprepitant Dimeglumine API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Fosaprepitant Dimeglumine API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Fosaprepitant Dimeglumine API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Fosaprepitant Dimeglumine API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Fosaprepitant Dimeglumine API Market Size by Country
    • 11.3.1 Middle East & Africa Fosaprepitant Dimeglumine API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Fosaprepitant Dimeglumine API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Fosaprepitant Dimeglumine API Market Drivers
  • 12.2 Fosaprepitant Dimeglumine API Market Restraints
  • 12.3 Fosaprepitant Dimeglumine API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Fosaprepitant Dimeglumine API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Fosaprepitant Dimeglumine API
  • 13.3 Fosaprepitant Dimeglumine API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Fosaprepitant Dimeglumine API Typical Distributors
  • 14.3 Fosaprepitant Dimeglumine API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Fosaprepitant Dimeglumine API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Fosaprepitant Dimeglumine is the dimeglumine salt form of fosaprepitant, the water-soluble, N-phosphorylated prodrug of aprepitant, with antiemetic activity. Upon intravenous administration and rapid conversion to aprepitant, this agent binds selectively to the human substance P/neurokinin 1 (NK1) receptors in the central nervous system (CNS). This inhibits receptor binding of the endogenous substance P and prevents substance P-induced emesis.
    This report is a detailed and comprehensive analysis for global Fosaprepitant Dimeglumine API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Fosaprepitant Dimeglumine API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Fosaprepitant Dimeglumine API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Fosaprepitant Dimeglumine API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Fosaprepitant Dimeglumine API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Fosaprepitant Dimeglumine API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Fosaprepitant Dimeglumine API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Tecoland Corporation, Wisdom Pharmaceutical Co., Ltd., Glenmark Pharmaceuticals, Viwit Pharmaceuticals Limited, Piramal Enterprises limited, Farmhispania, S.A., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Fosaprepitant Dimeglumine API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥98%
    Purity<98%
    Market segment by Application
    Fosaprepitant Dimeglumine Injections
    Others
    Major players covered
    Dr. Reddy’s Laboratories Ltd.
    Tecoland Corporation
    Wisdom Pharmaceutical Co., Ltd.
    Glenmark Pharmaceuticals
    Viwit Pharmaceuticals Limited
    Piramal Enterprises limited
    Farmhispania, S.A.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Fosaprepitant Dimeglumine API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Fosaprepitant Dimeglumine API, with price, sales quantity, revenue, and global market share of Fosaprepitant Dimeglumine API from 2020 to 2025.
    Chapter 3, the Fosaprepitant Dimeglumine API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Fosaprepitant Dimeglumine API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fosaprepitant Dimeglumine API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Fosaprepitant Dimeglumine API.
    Chapter 14 and 15, to describe Fosaprepitant Dimeglumine API sales channel, distributors, customers, research findings and conclusion.

    Buy now